Amgen 2009 Annual Report Download - page 110

Download and view the complete annual report

Please find page 110 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Exhibit No. Description
4.18 Indenture, dated as of February 17, 2006 and First Supplemental Indenture, dated as of June 8,
2006 (including form of 0.375% Convertible Senior Note due 2013). (Filed as exhibit to
Form 10-Q for the quarter ended June 30, 2006 on August 9, 2006 and incorporated herein by
reference.)
4.19 Corporate Commercial Paper - Master Note between and among Amgen Inc., as Issuer, Cede &
Co., as Nominee of The Depository Trust Company, and Citibank, N.A., as Paying Agent. (Filed
as an exhibit to Form 10-Q for the quarter ended March 31, 1998 on May 13, 1998 and
incorporated herein by reference.)
4.20 Officers’ Certificate of Amgen Inc. dated as of May 30, 2007, including forms of the Company’s
Senior Floating Rate Notes due 2008, 5.85% Senior Notes due 2017 and 6.375% Senior Notes due
2037. (Filed as an exhibit to Form 8-K on May 30, 2007 and incorporated herein by reference.)
4.21 Registration Rights Agreement, dated as of May 30, 2007, among Amgen Inc. and Morgan
Stanley & Co. Incorporated, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays
Capital Inc., Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co., Citigroup Global
Markets Inc., J.P. Morgan Securities Inc. and Lehman Brothers Inc. (Filed as an exhibit to
Form 8-K on May 30, 2007 and incorporated herein by reference.)
10.1+ Amgen Inc. 2009 Equity Incentive Plan. (Filed as Appendix A to Amgen Inc.’s Proxy Statement
on March 26, 2009 and incorporated herein by reference.)
10.2+* Form of Stock Option Agreement and Restricted Stock Unit Agreement for the Amgen Inc. 2009
Equity Incentive Plan.
10.3+* Amgen Inc. 2009 Performance Award Program (As Amended and Restated on December 4,
2009).
10.4+ Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program.
(Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2009 on November 6, 2009
and incorporated herein by reference.)
10.5+ Amgen Inc. 2009 Director Equity Incentive Program. (Filed as an exhibit to Form 8-K on May 8,
2009 and incorporated herein by reference.)
10.6+ Form of Grant of Non-Qualified Stock Option Agreement and Restricted Stock Unit Agreement
for the Amgen Inc. 2009 Director Equity Incentive Program. (Filed as an exhibit to Form 8-K on
May 8, 2009 and incorporated herein by reference.)
10.7+ Amgen Supplemental Retirement Plan (As Amended and Restated effective January 1, 2009.)
(Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on November 7, 2008
and incorporated herein by reference.)
10.8+ Amendment and Restatement of the Amgen Change of Control Severance Plan (As Amended
December 9, 2008). (Filed as an exhibit to Form 10-K for the year ended December 31, 2008 on
February 27, 2009 and incorporated herein by reference.)
10.9+ Amgen Inc. Executive Incentive Plan. (As Amended and Restated effective January 1, 2009.)
(Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on November 7, 2008
and incorporated herein by reference.)
10.10+ Amgen Inc. Executive Nonqualified Retirement Plan. (As Amended and Restated effective
January 1, 2009.) (Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on
November 7, 2008 and incorporated herein by reference.)
10.11+ Amgen Nonqualified Deferred Compensation Plan (As Amended and Restated effective January
1, 2009.) (Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on
November 7, 2008 and incorporated herein by reference.)
98